1. Molecular diagnosis for a fatal case of very long-chain acyl-CoA dehydrogenase deficiency in Hong Kong Chinese with a novel mutation: a preventable death by newborn screening.
- Author
-
Siu WK, Mak CM, Siu SL, Siu TS, Pang CY, Lam CW, Kwong NS, and Chan AY
- Subjects
- Acyl-CoA Dehydrogenase, Long-Chain blood, Acyl-CoA Dehydrogenase, Long-Chain deficiency, Congenital Bone Marrow Failure Syndromes, Fatal Outcome, Heterozygote, Hong Kong, Humans, Infant, Infant, Newborn, Lipid Metabolism, Inborn Errors genetics, Lipid Metabolism, Inborn Errors prevention & control, Male, Mitochondrial Diseases genetics, Mitochondrial Diseases prevention & control, Muscular Diseases genetics, Muscular Diseases prevention & control, Mutation, RNA Splicing genetics, Sequence Analysis, DNA, Siblings, Tandem Mass Spectrometry, Acyl-CoA Dehydrogenase, Long-Chain genetics, Lipid Metabolism, Inborn Errors diagnosis, Mitochondrial Diseases diagnosis, Muscular Diseases diagnosis, Neonatal Screening
- Abstract
Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is one of the most common fatty acid oxidation defects that cause sudden unexpected deaths in infants. The death attributed to VLCAD deficiency can be prevented by early diagnosis with expanded newborn screening using tandem mass spectrometry. A favorable outcome can be achieved with early diagnosis and prompt treatment. However, such newborn screening has not yet been available in Hong Kong. We report a 2-month-old boy who succumbed 5 hours after admission with the diagnosis of VLCAD deficiency confirmed by genetic analysis performed after death. The patient was compound heterozygous for a novel splicing mutation ACADVL NM_000018.2:c.277+2T>G; NC_000017.10:g.7123997T>G and a known disease-causing mutation ACADVL NM_000018.2:c.388_390del; NP_000009.1: p.Glu130del. Family screening was performed for at-risk siblings. The rapid downhill course of the patient clearly illustrates the need of newborn screening for early diagnosis. Our patient was asymptomatic before metabolic decompensation. However, once metabolic decompensation occurred, rapid deterioration and death followed, which obviated the opportunity to diagnose and treat. The only way to save these patients' lives and improve their outcome is early diagnosis and appropriate treatment. Therefore, we strongly urge the implementation of newborn screening using tandem mass spectrometry for VLCAD deficiency and other highly treatable inborn errors of metabolism in Hong Kong.
- Published
- 2012
- Full Text
- View/download PDF